AdaptHealth reported a third-quarter net loss attributable to the company of $168.2 million, compared to net income of $10.2 million in the prior-year period. The deterioration was primarily driven by an $184.8 million pre-tax goodwill impairment charge related to its Respiratory Health and Wellness at Home reporting units. Net revenue increased 10.9% to $745.6 million, while Adjusted EBITDA declined slightly to $141.9 million from $146.1 million. The company also revised its full-year financial outlook upward, raising net revenue guidance to a range of $2.88 billion to $2.90 billion and Adjusted EBITDA guidance to $510 million to $525 million. Additionally, the filing notes that the Hart-Scott-Rodino waiting period for the pending $235.0 million sale of its Diabetes Health business has been cleared. AdaptHealth is a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment and supplies.
